SKP2 anticorps (C-Term)
-
- Antigène Voir toutes SKP2 Anticorps
- SKP2 (S-Phase Kinase-Associated Protein 2 (SKP2))
-
Épitope
- C-Term
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SKP2 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC)
- Specificité
- SKP2/p45 Antibody detects endogenous levels of total SKP2/p45.
- Homologie
- Pig,Bovine,Horse,Sheep,Rabbit,Dog,Chicken
- Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogène
- A synthesized peptide derived from human SKP2/p45, corresponding to a region within C-terminal amino acids.
- Isotype
- IgG
- Top Product
- Discover our top product SKP2 Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20 °C. Stable for 12 months from date of receipt.
- Date de péremption
- 12 months
-
-
S-phase kinase-associated protein 2 impairs the inhibitory effects of miR-1236-3p on bladder tumors." dans: American journal of translational research, Vol. 10, Issue 3, pp. 731-743, (2018) (PubMed).
: "
-
S-phase kinase-associated protein 2 impairs the inhibitory effects of miR-1236-3p on bladder tumors." dans: American journal of translational research, Vol. 10, Issue 3, pp. 731-743, (2018) (PubMed).
-
- Antigène
- SKP2 (S-Phase Kinase-Associated Protein 2 (SKP2))
- Autre désignation
- SKP2 (SKP2 Produits)
- Synonymes
- anticorps FBXL1, anticorps FBL1, anticorps FLB1, anticorps p45, anticorps RGD1562456, anticorps S-phase kinase-associated protein 2 (p45), anticorps S-phase kinase associated protein 2, anticorps Skp2, anticorps SKP2
- Sujet
-
Description: Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins involved in cell cycle progression, signal transduction and transcription. Specifically recognizes phosphorylated CDKN1B/p27kip and is involved in regulation of G1/S transition. Degradation of CDKN1B/p27kip also requires CKS1. Recognizes target proteins ORC1, CDT1, RBL2, KMT2A/MLL1, CDK9, RAG2, FOXO1, UBP43, and probably MYC, TOB1 and TAL1. Degradation of TAL1 also requires STUB1. Recognizes CDKN1A in association with CCNE1 or CCNE2 and CDK2. Promotes ubiquitination and destruction of CDH1 in a CK1-Dependent Manner, thereby regulating cell migration.
Gene: SKP2
- Poids moléculaire
- 47kDa
- ID gène
- 6502
- UniProt
- Q13309
- Pathways
- Mitotic G1-G1/S Phases
-